VEGFR3 as a novel modulator for PAH

Oncotarget. 2017 Sep 28;8(49):84610-84611. doi: 10.18632/oncotarget.21295. eCollection 2017 Oct 17.
No abstract available

Keywords: BMPR2; VEGFR3; pulmonary hypertension; signaling.

Publication types

  • Editorial